IMBRIA
Live / Registered — Registered (as of 06 Aug 2024)
What this means for you
Registered since 06 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88985327
- Registration number
- 7469123
- Mark type
- Stylized text
- Filed
- 14 Nov 2018
- Published for opposition
- 28 Feb 2023
- Registered
- 06 Aug 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for treatment of cardiovascular diseases
Owner
- Imbria Pharmaceuticals, Inc., Boston, MA, US
- Imbria Pharmaceuticals, Inc., Boston, MA, US
- Imbria Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 06 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2024 — ASSIGNED TO LIE
- 10 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Apr 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 04 Apr 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jan 2024 — NON-FINAL ACTION E-MAILED
- 08 Jan 2024 — SU - NON-FINAL ACTION - WRITTEN
- 01 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE